India, April 12 -- Headaches are among the most common medical complaints worldwide, and a bugbear to many. From splitting or ...
AbbVie today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting (San Juan, ...